BioRestorative receives Nasdaq notice for late 10-Q filing; no immediate delisting

BioRestorative Therapies, Inc.

Nasdaq notified BioRestorative on May 22, 2024 of non-compliance with Listing Rule 5250(c)(1) due to delinquent Form 10-Q for Q1 2024.
Notice has no immediate effect on trading; company has 60 days to submit a plan to regain compliance.
Nasdaq may grant up to 180 calendar days from the 10-Q due date (Nov 11, 2024) for compliance.
Delay stems from ongoing restatement analysis previously disclosed in the May 24, 2024 Form 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.